Sylvie le Gledic
Profile
Sylvie le Gledic worked as a Director of Development & Regulatory Affairs at BioSystems International SAS.
She holds a doctorate degree from Université Paris 1 Panthéon-Sorbonne.
Former positions of Sylvie le Gledic
| Companies | Position | End |
|---|---|---|
BioSystems International SAS
 BioSystems International SAS BiotechnologyHealth Technology Biosystems International is a biotechnology company engaged in protein biomarker R&D using a unique and proprietary monoclonal antibody based proteomics technology (mAb proteomics), leading to the development of: Novel blood-based diagnostics for cancer and chronic diseases through the use of its innovative mAb proteomics approach, BSI is poised to translate its discoveries into novel blood-based diagnostics products for the early detection of cancer, a number of chronic diseases, and cancer recurrence with its most advanced program in the area of lung cancer currently under development. | General Counsel | 2014-03-05 |
Training of Sylvie le Gledic
| Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
BioSystems International SAS
BioSystems International SAS BiotechnologyHealth Technology Biosystems International is a biotechnology company engaged in protein biomarker R&D using a unique and proprietary monoclonal antibody based proteomics technology (mAb proteomics), leading to the development of: Novel blood-based diagnostics for cancer and chronic diseases through the use of its innovative mAb proteomics approach, BSI is poised to translate its discoveries into novel blood-based diagnostics products for the early detection of cancer, a number of chronic diseases, and cancer recurrence with its most advanced program in the area of lung cancer currently under development. | Health Technology |
- Stock Market
- Insiders
- Sylvie le Gledic
